This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jianyong Yang: Innovator in Medicinal Chemistry
Introduction
Jianyong Yang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel pharmaceutical compounds. His work focuses on addressing critical health issues such as diabetes and metabolic syndrome.
Latest Patents
Jianyong Yang holds a patent for "Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament." This invention relates to a novel phenoxyacetic acid derivative represented by the general formula (I). The preparation method and the use of a pharmaceutical composition containing the derivative are aimed at treating diabetes and metabolic syndrome. The phenoxyacetic acid derivatives exhibit excellent in vivo hypoglycemic activity, making them valuable for preventing or treating diabetes. He has 1 patent to his name.
Career Highlights
Jianyong Yang is affiliated with China Pharmaceutical University, where he conducts research and develops innovative medicinal solutions. His work has garnered attention for its potential impact on public health, particularly in managing diabetes.
Collaborations
Some of his notable coworkers include Hai Qian and Wenlong Huang, who contribute to his research endeavors and collaborative projects.
Conclusion
Jianyong Yang's innovative work in medicinal chemistry highlights his commitment to improving health outcomes through scientific research. His contributions, particularly in the area of diabetes treatment, underscore the importance of continued innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile